Oregon Medical Research Center
Oregon Medical Research Center is committed to research excellence and personalized patient care and our mission is to work with patients and medical companies to find future treatments for better health.
04/06/2021
Exciting times for people with atopic dermatitis/eczema!
https://nationaleczema.org/biologics-eczema-treatment/
Here is a great summary article from the National Eczema Association.
We've been involved with many of the trials of the new treatments discussed. Don't hesitate to reach out to us for more information.
Biologics Are Changing the Landscape of Eczema Treatment | National Eczema Association Over 25 new biologics are in development for treatment of atopic dermatitis, including the monoclonal antibody treatments Tralokinumab, Lebrikizumab, Nemolizumab %
04/06/2021
Interested in learning about a new psoriasis treatment (bimekizumab) in late-stage development? Watch Dr. Andrew Blauvelt being interviewed about the recent trial results.
Plaque Psoriasis on the M.D./alert Conversations Conversations in Plaque Psoriasis provides an in-depth look at novel treatments and new studies. Check in frequently for exclusive video interviews, Q&A’s and expert commentary on key issues facing clinicians today.
12/23/2020
Psoriasis gets featured in USA's Winter Wellness insert.
See a story on a patient's perspective of psoriasis and about his participation in a clinical study. See page 3.
Winter Wellness Issuu is a digital publishing platform that makes it simple to publish magazines, catalogs, newspapers, books, and more online. Easily share your publications and get them in front of Issuu’s millions of monthly readers. Title: Winter Wellness, Author: Mediaplanet_USA, Name: Winter Wellness, Lengt...
11/05/2020
Interesting info. about a new investigational treatment for psoriasis being studied at our site.
Nonliving microbe may be effective, safe oral treatment for psoriasis A drug comprised of a nonliving single strain commensal microbe showed signs of safe and effective treatment of mild to moderate psoriasis, according to a presentation at the European Academy of Dermatology and Venereology virtual congress.“EDP1815 is a nonlive pharmaceutical preparation of a....
11/04/2020
New studies now enrolling:
-Mild-to-Moderate Psoriasis
-Moderate-to-Severe Atopic Dermatitis (Eczema)
-Lichen Planus
Visit www.oregonmedicalresearch.com to learn more and SIGN UP today.
Click here to claim your Sponsored Listing.
Category
Contact the practice
Telephone
Address
1750 S Harbor Way, Suite 330
Portland, OR
97201
Opening Hours
| Monday | 7am - 4:30pm |
| Tuesday | 7am - 4:30pm |
| Wednesday | 7am - 4:30pm |
| Thursday | 7am - 4:30pm |